@article{3107180,
    title = "The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations",
    author = "Lazarus, J.V. and Safreed-Harmon, K. and Thursz, M.R. and Dillon, J.F. and El-Sayed, M.H. and Elsharkawy, A.M. and Hatzakis, A. and Jadoul, M. and Prestileo, T. and Razavi, H. and Rockstroh, J.K. and Wiktor, S.Z. and Colombo, M.",
    journal = "Seminars in Liver Disease",
    year = "2018",
    volume = "38",
    number = "3",
    pages = "181-192",
    publisher = "Thieme Medical Publishers Inc",
    issn = "0272-8087, 1098-8971",
    doi = "10.1055/s-0038-1666841",
    keywords = "disease elimination;  graft recipient;  hematologic disease;  hemodialysis patient;  hemophilia;  hepatitis C;  high risk population;  human;  Human immunodeficiency virus infection;  indigenous people;  migrant;  mixed infection;  people who inject drug;  prevalence;  priority journal;  prisoner;  Review;  cooperation;  disease eradication;  ethnology;  global health;  health care policy;  hepatitis C;  integrated health care system;  interdisciplinary communication;  international cooperation;  legislation and jurisprudence;  management;  nonbiological model;  organization and management;  risk factor;  stakeholder engagement;  transmission;  vulnerable population, antivirus agent, Antiviral Agents;  Cooperative Behavior;  Delivery of Health Care, Integrated;  Disease Eradication;  Global Health;  Health Policy;  Hepatitis C;  Humans;  Interdisciplinary Communication;  International Cooperation;  Models, Organizational;  Policy Making;  Prevalence;  Risk Factors;  Stakeholder Participation;  Vulnerable Populations",
    abstract = "The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World Health Organization to define ambitious targets for eliminating HCV as a public health threat by 2030. Formidable obstacles to reaching this goal can best be overcome through a micro-elimination approach, which entails pursuing elimination goals in discrete populations through multi-stakeholder initiatives that tailor interventions to the needs of these populations. Micro-elimination is less daunting, less complex, and less costly than full-scale, country-level initiatives to eliminate HCV, and it can build momentum by producing small victories that inspire more ambitious efforts. The micro-elimination approach encourages stakeholders who are most knowledgeable about specific populations to engage with each other and also promotes the uptake of new models of care. Examples of micro-elimination target populations include medical patients, people who inject drugs, migrants, and prisoners, although candidate populations can be expected to vary greatly in different countries and subnational areas. © 2018 by Thieme Medical Publishers, Inc."
}